23.10.2013 Views

Chairman's - FMC Corporation

Chairman's - FMC Corporation

Chairman's - FMC Corporation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>FMC</strong> CORPORATION<br />

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)<br />

NOTE 19: BUSINESS SEGMENT AND GEOGRAPHIC DATA<br />

Year Ended December 31,<br />

2009 2008 2007<br />

(in Millions)<br />

Revenue<br />

Agricultural Products .............................................. $1,051.6 $1,058.7 $ 889.7<br />

Specialty Chemicals ............................................... 753.1 764.5 659.5<br />

Industrial Chemicals ............................................... 1,026.7 1,296.9 1,087.1<br />

Eliminations ..................................................... (5.2) (4.8) (3.4)<br />

Total ........................................................... $2,826.2 $3,115.3 $2,632.9<br />

Income from continuing operations before income taxes<br />

Agricultural Products .............................................. 289.0 245.2 207.0<br />

Specialty Chemicals ............................................... 159.6 152.0 142.7<br />

Industrial Chemicals ............................................... 89.7 201.4 92.5<br />

Eliminations ..................................................... (0.1) (0.1) —<br />

Segment operating profit (1) ....................................... 538.2 598.5 442.2<br />

Corporate ........................................................ (44.1) (49.8) (52.3)<br />

Other income (expense), net ......................................... (27.5) (8.6) (12.0)<br />

Operating profit before the items listed below ........................... 466.6 540.1 377.9<br />

Interest expense, net ............................................... (27.0) (31.9) (34.9)<br />

Restructuring and other income (charges) (2) ............................ (132.8) (49.6) (164.9)<br />

Impairment of Perorsa joint venture (3) ................................<br />

Purchase accounting inventory fair value impact and other related inventory<br />

— (1.4) —<br />

adjustments (4) ................................................. (7.1) (2.3) —<br />

LIFO inventory correction adjustment (5) .............................. — — 6.1<br />

Gain from Astaris joint venture (6) ....................................<br />

Noncontrolling interest associated with restructuring and other income<br />

— — 0.4<br />

(charges) (7) ................................................... — — 1.4<br />

Loss on extinguishment of debt (8) .................................... — — (0.3)<br />

Provision for income taxes .......................................... (53.0) (125.4) (29.0)<br />

Discontinued operations, net of income taxes ............................ (18.2) (24.9) (24.3)<br />

Net income attributable to <strong>FMC</strong> stockholders ........................... $ 228.5 $ 304.6 $ 132.4<br />

Business segment results are presented net of noncontrolling interests, reflecting only <strong>FMC</strong>’s share of<br />

earnings. The corporate line primarily includes staff expenses, while other income and expense, net consists of<br />

all other corporate items, including LIFO inventory adjustments and pension income or expense.<br />

(1) Results for all segments are net of noncontrolling interests in 2009, 2008 and 2007 of $10.3 million,<br />

$17.0 million and $11.0 million, respectively, the majority of which pertain to Industrial Chemicals.<br />

(2) See Note 7. Amounts in 2009 related to Agricultural Products ($6.1 million), Industrial Chemicals ($71.8<br />

million), Specialty Chemicals ($31.0 million) and Corporate ($23.9 million).<br />

Amounts in 2008 related to Agricultural Products ($43.9 million), Industrial Chemicals ($14.2 million),<br />

Specialty Chemicals ($4.4 million) and Corporate ($12.9 million-gain).<br />

Amounts in 2007 related to Agricultural Products ($108.3 million), Industrial Chemicals ($43.3 million),<br />

Specialty Chemicals ($3.1 million) and Corporate ($10.2 million).<br />

110

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!